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A TEM protocol for quality assurance of in vitro 
cellular barrier models and its application to the 
assessment of nanoparticle transport mechanisms 
across barriers 
Dong Ye,a Kenneth A. Dawson*a and Iseult Lynch*b   
We report here a protocol to characterise and monitor the quality of in vitro human cellular 
barrier models using Transmission Electron Microscopy (TEM), which can be applied for 
transport assays, mechanistic studies and screening of drug/compound (including 
nanoparticle) penetration across such biological barriers. Data from two examples of 
biological barriers are given, namely the hCMEC/D3 endothelial blood-brain barrier model, 
and the Caco-2 intestinal epithelial barrier model, are given to show the general applicability 
of the method. Several aspects of this method are applicable to the quality assurance of in 
vitro barrier models, e.g., assessment of the multi or mono-layer structure of the endothelial 
cells; identification of any potential “holes” in the barrier that could confound transport 
assay results; validation of tight junction expression; and determination of the types and 
amounts of key cellular organelles present in the barrier to account for any significant 
changes in phenotype that may occur compared to the in vivo situation. The method 
described here provides a key advantage in that it prevents loss of the filter membrane 
during monolayer sectioning, thereby preserving critical details associated with the basal 
cell membrane. Applicability of the protocol for other in vitro biological barriers, such as 
the blood-foetus, blood-testes, blood–cerebrospinal fluid (CSF) and air-lung barriers is also 
discussed. Additionally, we demonstrate the use of the method for assessment of 
nanoparticle transport across cellular barriers and elucidation of trancytosis mechanisms. 
Sequential events of cellular endocytosis, localisation and transcytosis can be described in 
detail by TEM imaging, revealing useful sub-cellular details that provide evidence for the 
mechanism of nanoparticle transport in the hCMEC/D3 blood-brain barrier model and the 
Caco-2 intestinal epithelial cell model. Potential artefacts resulting from the nanoparticles 
interacting with the transwell membranes can also be assessed. 
 
1. Introduction  
There are both ethical (animal welfare) and economic 
considerations driving the regulatory push towards the 
development and validation of alternative (in vitro) approaches 
for safety assessment of chemicals.1, 2 Specifically, the use of 
cells or tissues derived, where possible from humans, which are 
cultured under controlled conditions in the laboratory (in vitro 
methods) may provide an important, scientifically valid route 
for safety assessment. From an economic standpoint, 
conducting a 2-generation reproductive toxicity study, a 90-day 
toxicity study, and a developmental toxicity study costs close to 
one million dollars (in addition to approximately 5000 
animals). As such, in vitro methods can be seen (perhaps 
inappropriately) as a quick and cheap way to register a 
substance under REACH, based on justification of a waiver to 
conducting new animal experiments.1, 2 
 
In light of this regulatory push, a large number of in vitro 
toxicology assays are being proposed, developed, validated, and 
approved for regulatory use as alternatives to animal testing.3 
Such assays have also been proposed to have additional 
benefits (besides reducing the number of animals used and the 
cost of testing), by also reducing the quantity of test materials 
needed and increasing the predictive ability of testing by 
focusing more closely on relevant endpoints or adding 
mechanistic information.3 Validation is the process by which 
the reliability and relevance of a test method are established for 
a specific purpose, in order to ensure regulatory acceptance of 
the method worldwide. Thus, any new method has to exhibit its 
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usefulness and power in describing and predicting possible 
toxicity per se, in comparison with an established method that 
reflects the present standard.4   
 
A key challenge for in vitro methods is to reproduce the 
complexity of the in vivo situation. For example, the cell 
quantities and types in culture are usually very limited, and 
often there are simply not enough signalling molecules 
produced by the low volumes of cells relative to the volume of 
cell culture medium for signalling to function. Thus, many 
types of cell signalling may be lost in in vitro systems, such as 
contact-dependent cell signalling. Even in very well-studied 
and highly commercial areas such as in vitro fertilisation, the 
current methods do not succeed in mimicking the in vivo 
situation completely.5 
 
From a research standpoint, this need for alternative in vitro test 
methods provides multiple opportunities and challenges. 
Among the most important tissues to mimic in vitro are the 
biological barriers that have the dual functions of protecting 
delicate organs whilst allowing essential nutrients to pass 
through them. In vivo human biological barriers, such as lung 
aveolar-capillary barrier, the intestine, the blood-brain barrier 
and the blood-placenta barrier, are composed of epithelial and 
endothelial cells which are associated within junction-anchored 
networks. All of these biological barriers share several common 
functions, including: (1) regulation of the permeability of 
biological fluids and balancing of fluid homeostasis; (2) 
separation of fluid compartments; and (3) protection of human 
micro-environments from harmful pathogens.6 However, due to 
variances in cell type, location and function, different barrier 
structures have distinct metabolic mechanisms and significance 
in terms of their function.  
 
A major research and regulatory goal is thus to establish and 
validate analogous in vitro models for biological barriers and to 
utilise them as screening tools to assess both exposure (amount 
of a compound that crosses the barriers) and impacts (effects 
such as toxicity or drug efficacy) of compounds for risk 
assessment and regulatory purposes. Key aspects of in vitro 
barrier models that require validation include barrier 
morphology and functionality. Epithelial and endothelial 
cellular barriers can grow into communicating cell-cell 
networks due to cell polarization and differentiation. Once 
confluent, they can form morphological and functional cell 
barriers akin to their “in vivo” counterparts, and impart a degree 
of restriction for transport of biomolecules via expression of 
tight junctions.7-11 Utilising a transwell filter membrane set-up 
as previous reports (see Fig. 1),10, 11 epithelial and endothelial 
cells established on transwells are usually polarised and 
prompted to communicate (via signalling molecules) between 
the apical and basolateral chambers, such that they can acquire 
sufficient differentiation to function as barriers.7-9, 12-14 Tight 
junctions expressed in these in vitro models are usually thought 
to be a critical standard with which to discriminate a well-
differentiated barrier from loosely associated barriers. Due to 
cell polarisation, endogenous bio-markers, such as junctional 
proteins, and transport related proteins that are specifically 
expressed in vivo, are subsequently expressed in these barriers. 
Figure 1. Representation of a transwell-based approach for in 
vitro biological barrier models.  
 
The application of such transwells has been utilised to study a 
range of end-points such as transport, absorption and secretion 
of molecules, access into or out of polarised cells, mobility-
related microbial pathogenesis, interactions between co-
cultured cell types and so on. Despite the transwell approach 
being well established and widely used in cell biology since its 
introduction in 1953,15 there have been persistent concerns that 
in vitro barriers do not fully mimic the in vivo situation.  
Potential reasons for this could include incomplete surface 
coverage, or overgrowth of the cells leading to multiple layers, 
either of which could lead to significant differences compared 
to the cell monolayer structure in vivo. However, to date, few 
studies have imaged the morphology of in vitro cellular barriers 
in detail as a quality control step to confirm their functionality, 
relying instead on the older established approaches of transport 
studies using fluorescently-labelled dextrans of specific 
molecular weights or electrical resistance studies across the 
barrier cells.8, 13, 16 Indeed, recommendations from the ECVAM 
study of available in vitro alternatives for a Blood-Brain Barrier 
(BBB) included the need for: (1) further development, 
characterisation and standardisation of in vitro models; (2) 
standard protocols for the different models; and (3) methods to 
characterise (a) the functional expression of transporter 
mechanisms and (b) the closeness of morphology to that of the 
in vivo system. 17 
 
Here we report a Transmission Electron Microscopy (TEM) 
based method to monitor the morphological quality of in vitro 
biological barrier models and to evaluate cell-cell interactions. 
The method provides direct visualisation of the barrier cells, 
their organisational structure and format, and allows any 
defects in the layer to be identified as a quality control tool 
prior to transport studies. TEM imaging, with its high 
magnification is capable of scrutinizing ultrastructures from 
cell level to nano-scale level. The general applicability of the 
method to in vitro biological barriers is demonstrated using two 
distinct barrier models: the human capillary microvascular 
endothelial D3 (hCMEC/D3) cell model of the human brain 
blood-brain barrier (BBB) and the human colon intestinal Caco-
2 model of the human intestinal barrier.   
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Possible applications of  the protocol for TEM imaging of 
barrier models, could be: (1) to probe any defect or 
imperfection upon barrier formation (such as multilayer or 
monolayer discrepancy, holes in the layers and other related 
issues that confound permeability and absorption tests); and (2) 
to examine tight junction or other subcellular components. 
Additionally, we show the application of the method to 
investigation of the mechanism of uptake and transport of 
nanoparticles, which have a size that is suitable for detection by 
TEM, into and across biological barriers. Thus, TEM imaging 
can also be used to identify and (semi)quantify nanoparticle 
uptake, localisation and transport across biological barriers,18 
both for exposure and impact studies. The present protocol 
provides an excellent addition to the published protocol for 
preparation of cells for assessing ultrastructural localisation of 
nanoparticles with TEM,19 extending it to the study of the 
morphology of biological barriers and for quality assurance of 
barrier morphology & function. 
 
Nanomedicine has recently emerged as a hot topic, since 
nanosized (1-100 nm) materials can interact with endogenous 
cellular machinery and access sub-cellular locations unavailable 
to conventional molecular drugs, as a result of their small size 
and large surface areas for protein binding. However, there is 
also significant scope for nanoparticles not intended to cross 
biological barriers to do so, and thus, as part of an assessment 
of the potential health implications of nanotechnologies, 
detailed understanding of the mechanisms of nanoparticle 
transport into and across biological membranes, utilising well 
established in vitro models, is urgently needed.  Inclusion of 
TEM images for quality control of the in vitro barriers as a pre-
requisite to uptake and transport studies would go a long way 
towards facilitating cross-comparison of studies and towards 
validating the comparability of the in vitro models as 
alternatives to in vivo biodistribution and biokinetics studies. 
Coupling these with TEM images of the nanoparticle sub-
cellular localisation (including at the basal membrane) can also 
provide mechanistic insights.   
 
The protocol presented here consists of several techniques 
including hCMEC/D3 cell and Caco-2 cell culture, microtome 
sectioning, cell monolayer histology processing and TEM 
imaging, which are each described in detail. Typical results 
regarding the morphology of cells growth on filters, tight 
junction structures and representative subcellular components 
are demonstrated to illustrate the versatility of the protocol in 
underpinning subsequent transport and mechanistic studies. 
 
2. Materials and Methods 
2.1 Materials 
 
hCMEC/D3 cells were obtained under license from INSERM, 
France and used for experiments between passage 25 and 35.12 
Growth medium and assay medium were used for hCMEC/D3 
cell propagation and barrier forming respectively (see Reagent 
Setup). Caco-2 cells were obtained from ATCC and passage 
numbers used were between 53-75, but it is possible to use cells 
with lower or higher passage numbers (e.g., 30-40).7 Culture 
medium for Caco-2 was prepared as described in the Reagent 
Setup. 0.01 % Typsin/EDTA solution and foetal bovine serum 
(FBS, non-heated inactivated) were from Biosciences (Ireland). 
Hank's balanced salt solution (HBSS) was from Gibco 
(Ireland). Type I rat tail collagen (see Reagent Setup), HEPES 
buffer, Triton X-100, glutaraldehyde solution, osmium 
tetroxide solution, absolute ethanol (99.8 % purity) (see 
Reagent Setup) and DMSO (99.5 % purity) were all purchased 
from Sigma (Ireland). Sorensen’s buffer was prepared as per 
the reported method20 (see Reagent Setup). Epoxy resin 
preparation kit was purchased from Agar Scientific (Ireland). 
12 nm human serum albumin functionalised-gold nanoparticles 
and 50 nm non-modified SiO2 nanoparticles were prepared as 
per reported methods.10, 21 
 
Cells were grown in a 37 oC incubator with CO2 connection (5 
% CO2 in air) and humidified with a water atmosphere. For 
hCMEC/D3 cell culture, 25 cm2 collagen pre-coated culture 
flasks (BD, USA) were used, and for Caco-2 cell culture 
various non-collagen coated flasks (Cap-vented flasks, with 
area 25 cm2 or 75 cm2, from Greiner Bio-One, Ireland) were 
utilised. Filters were purchased from Corning Costar (USA), 
including polyester membrane (PET) pore size 0.4 μm and 3.0 
μm, and PTFE membrane pore size 3.0 μm, all with a growth 
area of 1.12 cm2. 12-well culture plates with lids were also 
ordered from Corning Costar. Transmission electron 
microscope (TEM, TECNAI 12) was from FEI (USA). The 
microtome used for ultra-thin section preparation was a Leica 
EM UC6 (Ireland). The cell culture laminar flow fume hood 
was from Heraeus (Germany). A diamond knife was purchased 
from Diatome (USA). Copper grids (200 meshes) and other 
TEM imaging tools were obtained from Agar Scientific (USA). 
Light Microscopy was accessed via the UCD imaging facility. 
Glutaraldehyde, osmium tetroxide, ethanol, toluidine blue 
(tolonium chloride), uranyl acetate and lead citrate were 
purchased from Laboratory Instruments & Supplies, Ireland. 
 
2.2 Reagent setup 
 
hCMEC/D3 cell growth medium was prepared from EGM-2 
basal medium supplemented with VEGF, IGF-1, EGF, bFGF, 
2.0 % FBS, ascorbate, gentamycin and hydrocortisone, as 
recommended by the manufacturer (Lonza Bioscience, Ireland) 
and literature.8, 12 For the assay medium, EGM-2 basal medium 
was supplemented only with bFGF, 2.5 % FBS, hydrocortisone, 
gentamycine and 10 mM HEPES as reported in the literature.9, 
10, 12, 22 Type I rat tail collagen was diluted in sterile de-ionized 
water to a working concentration of 0.1 mg/ml, according to the 
manufacturer (Sigma, Ireland).  
 
For Caco-2 culture medium, Dulbecco's Modified Eagle 
Medium (DMEM, 500 ml) was supplemented with high 
glucose (4500 mg/L D-glucose), sodium pyruvate (Gibco, 
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Biosciences), 10 % FBS, 5 ml penicillin-streptomycin (10,000 
U/ml) and 5 ml non-essential amino acids (100X) (Gibco 
Biosciences, Ireland). Sorensen’s phosphate buffer was 
prepared from two separate solutions, A and B (A is 0.2 M 
Na2HPO4∙2H2O; B is 0.2 M NaH2PO4∙H2O). At pH 7.4, 
Sorensen’s buffer was freshly prepared by mixing 40.5 ml 
solution A with 9.5 ml solution B plus 50 ml de-ionized water. 
2.5 % Glutaraldehyde fixative was prepared with Sorensen’s 
buffer. Osmium tetroxide post-fixative was diluted in de-
ionised water to 1 %. For specimen dehydration, absolute 
ethanol was diluted with de-ionised water to 30 %, 50 %, 70 % 
and 90 %. Epoxy resin mixture was prepared as per the 
manufacturer’s instructions. For a better dispersion, human 
albumin-modified Gold nanoparticles were pipetted several 
times to disperse potential nanoparticle agglomerates before 
dilution with 2 % FBS assay medium to a working 
concentration of 50 µg/ml; non-modified Silica nanoparticles 
were dispersed with bath sonication at 25 oC for 2-5 min in 
order to agitate any agglomerates, and subsequently added to 
HBSS buffer supplemented with 10 % FBS to reach the desired 
concentration of 100 μg/ml and mixed thoroughly. Note that 
nanoparticle solutions should be always made freshly 
immediately prior to experiments, and their dispersion quality 
could be monitored via Dynamic Light Scattering or an 
alternative particle sizing technique to ensure the sample has 
not agglomerated in the assay medium.  
 
2.3 Methods 
 
The detailed information for this TEM protocols has been laid 
out as in following sections, and for associated technical issues, 
if any, readers are encouraged to consult our troubleshooting 
list shown in Table 1. 
 
Problem Solution 
Defrosted cells are not confluent or 
reach confluence slowly during cell 
culture 
Ensure removal of DMSO before culturing cells in a culture flask. A 
smaller-growth area flask is recommended to speed up cell growth. 
Check cell density and storage time of the cryogenic stock. 
Multilayer formation Several methods can be used to improve this: Reduce cell seeding 
density on the transwell and avoid seeding aggregated cells. Improve 
collagen coating on transwell membrane. 
A low TEER or a high FD4 value in 
the barrier model (If applicable) 
Improve the cell culture to allow tight junctions to be well-
developed. 
Blank Filter not permeable  Soak transwell filter in water before cell seeding. Test equilibration 
capacity of nanoparticles/test molecules on different types of porous 
membranes. Optimise collagen coating to minimize blockage of 
transwell pores. 
Cell barrier layer becomes completely 
removed from the transwell 
membrane 
Cell seeding density is too high or collagen coating is too thick, 
causing multi-layer formation. Optimise cell seeding density and 
collagen coating. 
Cells migrate through transwell pores Improve collagen coating or change to another transwell with a 
smaller pore size. 
Imaging displays holes in the barrier Improve cell culture procedure and collagen coating. Check cell 
seeding density and number of growth days. 
Nanoparticles precipitated  Increase sonication time, or if not applicable, improve chemical 
synthesis. 
Darkened transwell membranes in 
specimen 
Ensure osmium tetroxide is completely removed and rinsed with 
washing buffer at the end of the fixation step. 
Bubbles underneath the transwell in 
epoxy resin embedding 
Avoid vigorous mixing of epoxy resin and take extra care to check 
bubble formation during embedding. 
Specimen is too hard to cut  Always use manufacturer-recommended recipe for resin preparation. 
Holes in sections  Improve ethanol dehydration, resin embedding and section staining 
procedures. Alternatively, a vacuum oven may be used to help 
infliltrate pores of transwells and remove air bubbles from resin. 
Filter breaks away from Epoxy resin. Avoid using liquid nitrogen to separate the plastic surrounding the 
embedded sample. Use a blade to manually remove plastic and 
prepare block face. 
Sections are washed away from grids 
during staining 
Dry sections for a longer time (e.g., overnight) prior to start staining 
and always avoid vigorous washing during the staining process. 
Block face always wets during cutting 
and section may drag back over knife 
Water level in the boat of diamond knife is too high and the block 
face of specimen is too big. 
Journal Name ARTICLE 
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edge. 
Heavy metal particle contamination 
on sections 
Improve washing and drying steps during uranyl acetate and lead 
citrate staining.  
Poor image contrast Improve the staining with uranyl acetate and lead citrate. Adjust 
brightness and contrast settings in TEM camera. 
 
Table 1. Troubleshooting table for technical issues that may arise during application of this EM protocol. 
2.3.1 Cultivation of hCMEC/D3 cell monolayer grown on 
permeable supports  
 
hCMEC/D3 cells were cultured as per the method reported 
previously.8-12, 22 A Cryogenic stock containing about 1 × 106 
hCMEC/D3 cells was thawed at room temperature. Once 
defrosted, cells were gently suspended with pre-warmed assay 
medium and spun down for 3 min at 1500 rpm. The supernatant 
was then removed. Note that cryogenic stocks may contain 
DMSO, which is a cytotoxic agent for cell culture and therefore 
must be removed during centrifugation. The cell pellet was 
suspended in fresh growth medium and cultured in a 25 cm2 
collagen coated flask. Cell medium was changed every 2-3 
days. Cells should be passaged twice before used. After cells 
reached 90 % confluence, hCMEC/D3 cells were split by 
trypsinization. To do this, cell medium was firstly removed by 
aseptic decantation and rinsed with PBS (5 ml per 25 cm2 
flask). Typsin/EDTA solution was added in (3 ml per 25 cm2 
flask). Cells were incubated at 37 oC for 1-3 min for 
detachment, tapping the bottom of flask to dislodge cells if 
necessary. After observing detachment in an inverted 
microscope, cells were de-trypsinized by adding 3 ml assay 
medium (containing 2 % FBS). Cells were spun down at 1,500 
rpm for 3 min and re-suspended in assay medium. It is 
recommended that cell solution should be pipetted up and down 
a few times and thoroughly dispersed, in order to avoid 
formation of cell aggregates.    
 
For barrier seeding, we used 12-well transwell plates of 
different pore sizes. In some cases, transwells (e.g., Corning 
Polyester or Polycarbonate) may require collagen coating. To 
do so, 0.2-0.5 ml 0.1 mg/ml collagen solution is added to the 
apical chamber of transwells and incubated for 24 hours at 37 
oC in a dry incubator (Collagen solution will dry out and 
deposit on the transwell membrane). Transwells were washed 
with PBS before use. It was noted that an optimal density of 
collagen coating may improve confluent morphology and 
barrier formation of hCMEC/D3 cells, although this is still 
subject to using a suitable type of transwell (i.e. suitable pore 
size) to avoid potential cell migration through bigger pores 
(Supplementary Fig. 2). The transwell filters (growth area 1.12 
cm2) were soaked in 0.5 ml and 1.5 ml assay medium in the 
apical and basolateral chambers respectively for at least 10 min 
at 37 oC after which the medium was removed. 0.5 ml cell 
solution with an optimal seeding density of 5.0 × 104 cells was 
added to the apical chamber and 1.5 ml fresh assay medium to 
the basal chamber. After cells were cultured at 37 oC for 5-6 
hours, the apical medium was removed and replaced with pre-
warmed fresh medium, in order to avoid any non-attached cells 
forming a multilayer. Cell medium was then changed every 3 
days for 7 days, by aspirating medium from the basolateral side, 
then from the apical side and adding assay medium to the apical 
chamber, then to the basolateral chamber (medium volumes as 
stated before). Note that when pipetting medium, care should 
be taken to avoid any physical contact with the filter surface 
which may damage monolayer integrity. On the 7th day, 
medium should be changed before the experiment (whether 
quality assurance or transport assay) as starvation may affect 
protein expression in the endothelial cell monolayer. Tight 
junction expression is validated using well established assays 
such as transport of 4KDa FITC-Dextran (FD4) and Trans-
endothelial Electrical Resistance (TEER), as per our previous 
report.11  
 
2.3.2 Cultivation of Caco-2 cell monolayer grown on 
permeable supports  
 
Caco-2 cells were cultured according to previous reports.7, 14, 23 
A cryogenic Caco-2 cell stock (10 % DMSO and 10 % FBS) 
was thawed at room temperature and immediately replenished 
with pre-warmed DMEM complete medium. Cells were spun 
down at 1500 rpm for 3 min and the supernatant removed 
completely (for DMSO). Cells were then re-suspended in 
DMEM complete medium and bottled in a 25 cm2 tissue 
culture-treated flask (filter-vented). Caco-2 cells are usually 
slow to reach confluent (approx. 7 days) following cryogenic 
storage in liquid nitrogen. Depending on initial cell numbers 
prepared in the frozen stock, revival time may vary. We suggest 
using a small flask to shorten time to confluence, or 
alternatively reviving more than one cryogenic cell stock to 
speed up the experimental. Once confluent, cells were further 
grown in a larger flask (growth area 75 cm2). As for 
hCMEC/D3 cells, Caco-2 cells were passaged at least twice 
before use. At 80-90 % confluence, cells were rinsed with PBS 
twice (Note that vigorous washing with PBS should be avoided 
as the layer of Caco-2 cells covering the wall of a flask could 
be easily removed and lost). Typsin/EDTA solution was then 
added (5 ml for a 75 cm2 flask) and treated for 5 min at 37 oC, 
with periodic tapping of the bottom of flask to dislodge cell 
aggregates. Cells were then de-trypsinized by DMEM complete 
medium and centrifuged at 1500 rpm for 3 min. The pellet of 
cells was re-suspended in fresh medium and thoroughly mixed. 
In some cases, cell clumps may appear difficult to separate; we 
suggest stabilising the cell solution for 1 min to allow larger 
ARTICLE Journal Name 
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
cell aggregates to sediment and then transfer the upper 
supernatant (with more dispersed cells) for use. Cells were 
counted with trypan blue on a haemocytometer to ensure a 
viable cell concentration.  
 
For barrier seeding, transwell filters were soaked with fresh 
medium as stated for hCMEC/D3 cells. With a 12-well 
transwell plate (0.4 or 3.0 μm filter), 0.5 ml cell suspension 
containing 2×105 cells was added to the apical side and 1.5 ml 
DMEM fresh medium added to the basolateral side. Cells were 
cultured in an incubator for 5-16 hours before the apical 
medium was removed and changed, in order to reduce 
formation of a multilayer. Caco-2 cells were then grown for up 
to 21 days, with medium changed every two days up to 15 days 
and then every day until day 21 to obtain well-differentiated 
monolayers. The medium change was carried out using the 
same procedure as stated for the hCMEC/D3 cell barrier. Tight 
junction quality is also evaluated using TEER measurements to 
allow comparability with established literature.7 
 
2.3.3 Exposure of hCMEC/D3 and Caco-2 cell monolayers 
to nanoparticles (or other test compounds, e.g., drugs)  
 
For exposure of the hCMEC/D3 cell barrier, 12 nm albumin-
conjugated gold nanoparticles prepared in our lab were used at 
a concentration of 50 μg/ml as previously reported.10 Albumin 
is known to have a receptor in the BBB cells24, 25 and was 
therefore chosen to increase the likelihood of visualising 
nanoparticles inside the in vitro BBB model for demonstration 
purposes; For treatment of the Caco-2 cell barrier, we used 50 
nm non-modified SiO2 nanoparticles to demonstrate imaging 
evidence of Caco-2 uptake directly from EM, although previous 
studies reported Caco-2 model rarely internalised silica 
nanoparticles.26-30 A lower dose of silica nanoparticles such as 
25 μg/ml showed much more limited interaction with Caco-2 
barriers, compared with a higher one (100 μg/ml) using flow 
cytometry (See Supplementary Fig. 1a), we therefore used a 
higher dose (100 μg/ml) to amplify the chance of visualising 
nanoparticles under EM. We also demonstrated that silica 
nanoparticles were not toxic to Caco-2 cells at a range of doses 
(See Supplementary Fig. 1b). In addition to exposing barriers to 
nanoparticles alone (i.e. just in cell culture media), moreover, 
other biomolecules, such as serum proteins or antibodies, could 
also be added along with nanoparticles to enhance uptake.31, 32  
 
An orbital shaker was set up at 37 oC in an incubator with 
humidified atmosphere and 5 % CO2. Apical and basolateral 
medium were removed from barrier transwells on which 
barriers were 90% confluent, followed by rinsing of the barriers 
with fresh medium or buffer for 30-60 min (Assay medium for 
hCMEC/D3 cell barrier; 10mM HEPES supplemented HBSS 
buffer for Caco-2 cell barrier). Next, transwell filters were 
moved into another 12-well plate, which already contained 
fresh assay medium or HBSS (1.5 ml per well). Nanoparticle 
solutions were loaded into the apical chambers along the inner 
verge of the filters and placed into an orbital shaker set at 100 
rpm. Physical contact of pipette tips with filter membranes 
should be avoided while adding or emptying solutions as that 
may damage cell barriers that have formed. Exposure to the 
nanoparticle solutions was over 4 hours for hCMEC/D3 barriers 
and over 9 hours for Caco-2 barriers, although exposure times 
of up to 24 hours for Caco-233 or 48 hours for hCMEC/D39 can 
be easily achieved. After exposure, nanoparticle solution/media 
was emptied from both apical and basolateral sides of filters. 
Fresh PBS was applied and removed in order to wash off any 
remaining nanoparticles. It should be noted that nanoparticles 
may cross the monolayer and reach the basolateral 
compartment during the exposure, thus for enhanced image 
analysis, it is important to remove nanoparticles/solutions from 
both chambers of each transwell prior to performing fixation 
and embedding. Medium from the basolateral side may be used 
subsequently for quantification of nanoparticle transport11 via 
particle counting, fluorescence or other approaches. 
 
2.3.4 Fixation and embedding of cell monolayers grown on 
transwell filters  
 
The following procedures were performed at room temperature 
unless otherwise stated. Firstly, 2.5 % glutaraldehyde solution 
was added to the apical, then the basolateral chamber of 
transwell filters (0.5 ml and 1.5 ml respectively), and cell 
monolayers (hCMEC/D3 or Caco-2) were fixed for 1 hour. 
Note that glutaraldehyde is a toxic and volatile fixative and 
needs to be handled in a fume hood. Glutaraldehyde was then 
emptied and disposed of appropriately. Sorensen’s phosphate 
buffer was applied for 10 min to rinse off the fixative. 1 % 
osmium tetroxide (OsO4) was added to stain cell monolayers 
for 1 hour, adding 0.5 ml and 1.5 ml to the apical and 
basolateral chambers respectively. OsO4 embeds directly into 
cells to enable high contrast images of cells under the electron 
beam, without damaging lipid or protein structures. However, 
as with glutaraldehyde, OsO4 is a volatile, harmful poison and 
should be handled only in a fume hood and disposed of with 
extra care. After removal of OsO4, Sorensen’s phosphate buffer 
was applied for washing for 10 min. Next, dehydration of cell 
monolayers was carried out with ethanol at different 
concentrations as follows: 30 % ethanol on both sides of the 
filters for 10 min; 50 % ethanol for 10 min; 70 % ethanol for 10 
min; 90 % ethanol for 10 min; and finally, 100 % ethanol for 20 
min three times. Lids for transwell plates should be closed at all 
times, as ethanol may change its concentration by evaporation 
which could result in less effective dehydration. Cell 
monolayers were pre-embedded with a mixture of epoxy resin 
and ethanol (1:1 v/v) for 1 hour, followed by 2-hour embedding 
in full epoxy resin (100 %) at 37 oC, with 250 ml on the top and 
600 ml on the bottom. This step is to ensure that the ethanol 
evaporates completely during the incubation. Later, epoxy resin 
was removed completely and replaced with fresh resin. Note 
that resin should be gently added to both the top and bottom 
space of the transwell filters and enough used to submerge the 
transwell as a whole. Bubbles may form during this step, which 
should be carefully removed by using a pipette tip; the presence 
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of bubbles below the filter membranes should also be carefully 
checked: if any are observed the filters should be taken out 
from the resin and then slowly re-positioned in order to avoid 
bubble formation underneath. Resin is then polymerised in an 
oven at 65 oC for 24 hours. Note that the transwell filter lids 
should be removed prior to polymerisation. 
 
2.3.5 Specimen sectioning  
 
As demonstrated in Fig. 2a, the transwell resin block was fixed 
and positioned with its bottom upright. By using a saw, the 
block was cut to a depth of 3-4 cm, which is thicker than the 
filter membrane, along the cutting lines shown in Fig. 2b (the 
distance between a filter membrane and an acceptor well in 
Corning Transwells is 1 cm). The surrounding plastics and 
resins were removed by additional cutting in order to reveal the 
cubic block (Fig. 2c), where plastic, epoxy resin, filter 
membrane and epoxy resin were in alignment from left to right 
as demonstrated in Fig. 2d. Under a stereomicroscope, a razor 
blade was used to trim the top of the block until a black straight 
line (the flank of a transwell membrane) was clearly revealed, 
noting that the cell monolayer was located on the right hand 
side of the black line. As seen in Fig. 2e, the plastic layer was 
removed with a razor. The conventional method that avails of 
cooling with liquid nitrogen and heating with boiling water 
would not be recommended for removal of the plastic, as 
thermal expansion likely forces the resin and membrane layers 
to move apart and results in lower quality sections. A trapezoid 
shape pattern was then made by razor cutting as shown in Fig. 
2f and the periphery resin outside the pattern was cut out, so 
that a trapezoid-shaped block was revealed as shown in Fig. 2g. 
Lastly, the block was set up and positioned on the microtome. 
The diamond knife was adjusted to align it with the block 
surface. The boat of the diamond knife was filled with clean 
water and its level adjusted. The cutting thickness (80 nm) was 
set in the microtome, with a speed of 1-2 mm/sec. Sections then 
float and spread one after another on the boat of the diamond 
knife. The integral sections were obtained as trapezoid-shaped 
(Fig. 2h). For mounting of sections, copper grids of 3.05 mm 
diameter were used with 200 square mesh and with coating of 
choice. Finally, sections were air-dried for at least 1 hour.  
  
  
Figure 2. Schematic diagram for separating and sectioning a barrier-seeded transwell sample. (a) A resin-embedded transwell 
filter in an inverted position. (b) The cutting strategy is outlined with red lines to demonstrate the separation of a filter membrane-
localised block from the resin-embedded transwell. (c) An overview (red line) of the block sample after separation. (d) A view 
across the filter to show the different layers of materials in the sample block. From left to right: plastic (red line), epoxy resin, filter 
membrane and epoxy resin. (e) The cutting method is outlined with red lines to show how the plastic layer is removed without 
damaging the filter membrane. (f) After removal of the plastic, serial cuttings (red lines) are applied around the filter membrane. 
(g) The trimming block surface is revealed by removal of the peripheral resin before microtome sectioning. (h) Overview of an 
ultrathin section obtained by microtome sectioning.  
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2.3.6 Section staining 
 
Copper grids were placed face down and mounted onto droplets 
of uranyl acetate (2 %) for 20 min. Grids were picked out with 
a tweezers, and gently washed with de-ionized water and air 
dried for 5-10 min. Grids were mounted again onto lead citrate 
(0.4 %) for staining for 10 min. After brief washing, grids were 
air dried for at least 1 hour. It should be noted that vigorous 
washing should be avoided during staining as that may damage 
the integrity of sections. 
 
2.3.7 Transmission electron microscopy imaging 
 
For imaging, transmission electron microscopy (TEM, 
TECNAI 12) was operated at 120 kV. Before starting the 
instrument, liquid nitrogen was filled up to cool the wire “cold 
finger” of the microscope in order to balance the temperature of 
the electron column chamber. Condenser aperture, objective 
aperture, objective lens, and the electron beam were aligned 
successively. The grids were firstly loaded in the circular recess 
of the specimen-holder tip and inserted into the electron gun 
chamber. For image acquisition, objects of interest were 
photographed at both lower and higher magnification levels in 
order to illustrate morphological features of samples at different 
fields of view.  
 
3. Results  
3.1 Barrier morphology quality control 
 
Barriers composed of hCMEC/D3 and Caco-2 cells exhibited 
confluent and contact-inhibited morphology, as demonstrated in 
Fig. 3a and c, grown on 0.4 μm and 3.0 μm transwells (Fig. 3b) 
respectively. Both barriers completely covered the surface area 
of the transwell membranes, as shown in the two longitudinal 
views for barrier integrity given in Fig. 3a and 3c, respectively. 
Following fixation and embedding of the intact cell barriers on 
the transwells, cross sections of transwell membranes were cut 
using the microtome. Transwell filters were well preserved and 
closely attached under the layer of cells.   
 
Using TEM imaging, a much more detailed (and magnified) 
description of barrier morphology emerged, compared to other 
methods such as fluorescence microscopic imaging used to 
characterise and evaluate the same BBB barrier, as reported 
previously.22 Holes of different sizes in the porous membranes 
underneath the barrier cell layers could be observed. As 
expected, 3.0 μm PTFE membranes showed much bigger pores 
than 0.4 μm PET membranes with both cell types. TEM 
imaging showed that both hCMEC/D3 cells and Caco-2 cells 
formed a single layer (of endothelium or epithelium cells 
respectively) on the apical side of the transwell. 
Morphologically, the hCMEC/D3 endothelial monolayer (Fig. 
3d and 3e) was 3-4 times thinner than the Caco-2 epithelial 
monolayer, which was about 15-20 μm in thickness (Fig. 3f and 
3g). 
 
Caco-2 cells appeared rectangular-shaped with their nuclei 
staying close to the basal membrane (Fig. 3f and 3g). The cell 
boundaries between adjacent epithelial cells were merged 
without clear division. In comparison, hCMEC/D3 cell barriers 
consisted of  thin, elongated cells. Although different in 
morphology, both endothelial and epithelial cell monolayers 
were formed uniformly on the various transwell filters (as 
shown in Fig. 3d - 3g). 
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Figure 3. Morphology of hCMEC/D3 endothelial and Caco-2 epithelial cell barriers grown on transwell filters as demonstrated in 
(b, the picture from http://www.eandkscientific.com). Confluent barriers of hCMEC/D3 cells and Caco-2 cells after 7 and 21 days 
in culture, respectively. Both hCMEC/D3 (a) and Caco-2 (c) cell barriers were stained by toluidine blue and both images were 
taken with a 5X objective lens using a phase contrast microscope. Cross-sections for hCMEC/D3 monolayers with 0.4 μm PET (d) 
and 3.0 μm PTFE (e) transwells, and Caco-2 monolayers with 0.4 μm PET (f) and 3.0 μm PTFE (g) transwells were obtained and 
imaged, where the PTFE membranes generally appeared more porous than the PET ones. Caco-2 cells showed relatively bigger 
nuclei (N, as indicated) than hCMEC/D3 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Double layers of hCMEC/D3 cells growing on both 
sides of a 3.0 μm PET transwell membrane, due to apical-to-
basolateral migration of the cells through the pores of the filter. 
(a) The microtomic section of double cell layers was stained 
with toluidine blue and visualised with Light Microscopy. 
Regional cell attachments on the apical (b) and basolateral (c) 
sides of the transwell membrane were examined under TEM. 
 
In some cases, however, TEM imaging found that hCMEC/D3 
cells were able to form sandwich-like bi-layers on both sides of 
the 3.0 μm PET membranes (even where prelonged coating 
with collagen resulted in a relatively higher density), as shown 
in Fig. 4a and Supplementary Fig. 2. Presumably the cells may 
have migrated through the pores of the transwells and grown 
underneath by attaching to the bottom of transwell membrane, 
as described in Fig. 4b-4c. By comparing with a barrier 
monolayer formed on 3.0 μm PTFE membrane (collagen coated 
by the manufacturer) in Fig. 3e and 5b, it is postulated that 
collagen coating density and/or porosity of the chosen transwell 
type may contribute to the migration of cells through the filter. 
For a given transwell type, collagen coating density and 
porosity of transwells played important roles in formation of 
homogenous barriers. Barrier homogeneity was also influenced 
by transwell composition, even where the pore sizes are 
nominally the same according to the manufacturer, for example, 
3.0 μm PET versus 3.0 PTFE (Supplementary Fig. 2). 
 
Choice of transwell composion, pore size and collagen coating 
are important, but optimisation of the growth conditions is also 
necessary to avoid the formation of multilayers. Thus, 
multilayer formation (Fig. 5a) was also observed via TEM on 
3.0 μm PTFE transwell membranes, for example (Fig. 5c), 
using the hCMEC/D3 barrier model, and can be compared to 
the hCMEC/D3 monolayer formed on the same transwells (Fig. 
5b), as previously reported.10 The hCMEC/D3 cells seemed to 
undergo partial overgrowth on the transwell, potentially caused 
by cellular compatibility of transwells as well as sub-optimal 
growth conditions including barrier growth time or cell seeding 
density. Figure 5b shows cells grown using the optimised the 
seeding density of hCMECD3 cells (50,000 cells), with growth 
time (7 days) monitored in relation to tight junction formation. 
As can be seen from Figure 5b, optimal seeding density results 
in a good confluent morphology where cells were elongated 
and showed contact-inhibited features and a homogenous 
monolayer, compared to the barriers that were acquired from 
excess or insufficient seeded cell numbers (Supplementary Fig. 
3b and 3c). In addition, TEER values showed that the optimal 
seeding density generated a similar tight junction quality 
regardless of variance of pore sizes of the chosen transwells 
(Supplementary Fig. 3a), although the hCMEC/D3 model was 
reportedly low at TEER.8, 11, 13 Overall, all these distinct 
characteristics suggested that TEM imaging is a necessary tool 
to monitor the growth characteristics and ensure formation of a 
homogenous monolayer as part of barrier morphology quality 
assurance prior to transport studies. 
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Figure 5. An example of multilayer (a) or monolayer (b) formation determined using TEM imaging in order to monitor 
hCMEC/D3 overgrowth on 3.0 μm PTFE transwells during the protocol optimisation procedure. The highly porous transwell 
membrane without any cells seeded was also imaged as a reference (c). It should be noted that studies inadvertently performed on 
a multilayer would give false results, thereby emphasizing the need for careful quality control of barriers prior to studies. 
 
The paracellular space between adjacent cells in both 
hCMEC/D3 and Caco-2 cell barriers was observed to be sealed 
by tight junctions, which were visible as strong electron-dense 
structures (Fig. 6a and 6c). Additionally, to complement the 
information regarding quality of tight junctions form TEM, 
Triton X-100 was used as a chemical control for disruption of 
tight junctions. Tight junction disruption was observed in both 
barrier models using 4 KDa FITC-Dextran and TEER 
measurements in the presence of Triton X-100 (Supplementary 
Fig. 4a and 4b respectively).  
 
The sub-cellular compartments in the two barrier models are 
quite distinctive. In hCMEC/D3 monolayers, the cells normally 
have a big nucleus which occupies a large volume of the 
cytosolic space (Fig. 6b). Other major subcellular components, 
such as mitochondria, multivesicular bodies and lysosomes, are 
also observed (Fig. 6a and 6b). In Caco-2 monolayers, the 
apical cell membranes are covered by intensive microvilli (Fig. 
6c and 6d), a series of cellular membrane protrusions, which are 
involved in adsorption of nutrients. Within the intracellular 
compartment, in addition to mitochondria, multivesicular 
bodies, and lysosomes seen in TEM, Caco-2 cells also showed 
a large amount of ribosomes surrounding the nucleus (Fig. 6d). 
Endocytotic pits or vesicles were found in both hCMEC/D3 and 
Caco-2 cells (Fig. 6a and 6d), presumably undertaking a similar 
function of cellular uptake processes. Overall, as presented in 
Fig. 6, it is clear that the degree of sub-cellular ultrastructure 
visualised by TEM imaging offers an important tool to study 
morphological changes, barrier integrity and transport 
mechanisms across the cell barrier models. 
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Figure 6. Sub-cellular characteristics of hCMEC/D3 endothelial (a and b) and Caco-2 epithelial (b and d) cell barriers. Tight 
junctions were found to seal the paracellular space between adjacent cells in the endothelial (a) and the epithelial (c) cell 
monolayers. Different cellular compartments displayed in (b) and (d) included a variety of organelles. Abbreviations: BMV, basal 
membrane vesicle; EP, endocytic pit; L, lysosome; M, mitochondria; MV, multivesicular body; N, nucleus; R, ribosome; TJs, tight 
junctions; V, vesicle. 
 
3.2 Nanoparticle uptake and transport 
 
To characterise transport of nanoparticles across the 
hCMEC/D3 cell monolayer, 12 nm gold nanoparticles 
conjugated with human serum albumin were applied. After a 4-
hour incubation, albumin-gold nanoparticles demonstrated a 
series of active uptake events, which involved both endocytic 
and exocytic processes. As demonstrated in Fig. 7, vesicle 
sorting was observed to transport single albumin-gold 
nanoparticles within the cytoplasm of endothelial cells (Fig. 7a 
and 7b), presumably following cell membrane endocytosis (a 
related event for this, the membrane invagination in Fig. 7a that 
might lead to subsequent vesicle sorting). The endothelial 
paracellular space was tightly sealed by tight junctions (seen in 
Fig. 7b) thus paracellular transport was restricted. The 
conjugation of albumin to 12 nm gold nanoparticles was 
potentially responsible for initiating the observed vesicle 
sorting. Colocalisation of albumin-gold nanoparticles within 
lysosomal pathway-related organelles such as endosomes (Fig. 
7c) and lysosomes (Fig. 7d) was observed. The transport of 
albumin-gold nanoparticles was dominated by the recycling 
process of lysosomes, although the attached albumin was 
expected to lead to active transcytosis across endothelial cells. 
In all cases, the endo-lysosomal pathway played a major role in 
the internalisation of albumin-coated gold nanoparticles in the 
human brain endothelial cells, as the nanoparticles were linked 
with endogenous proteins thought to promote endothelial 
receptor-mediated transcytosis.24, 34, 35 Although it was only 
rarely observed from previous reports,10, 22 a transcytosis event 
was demonstrated in Fig. 7e, where an exocytotic vesicle 
docking the basal membrane containing a single gold 
nanoparticle inside could be observed, which seemed to 
discharge the nanoparticle into the basal compartment (Fig. 7f). 
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Figure 7. Translocation of 12 nm human serum albumin-gold nanoparticles (Au-NPs) (50 μg/ml) across the hCMEC/D3 
endothelial cell monolayer post 4-hour incubation. (a) Clathrin-coated pit cavity was invaginated on the apical membrane and Au-
NPs were found in sorting endocytic vesicles within cytosolic space (the arrows). (b) Au-NPs were trafficked to different 
cytoplasmic regions as indicated by the arrows. Au-NPs were found co-localised within the endosome (c) and lysosome (d) 
respectively. A rare event, whereby a single Au-NP exited the basolateral cell membrane from a vesicle, is shown in (e) and the 
Au-NP present in the basal compartment is observed (f). Abbreviations: EP, endocytic pit; ER, endoplasmic reticulum; EV, 
exocytic vesicle; E, endosome; L, lysosome; M, mitochondria; N, nucleus; TJ, tight junction.  
 
In the Caco-2 cell monolayer, nanoparticle internalisation was 
demonstrated using 50 nm SiO2 nanoparticles, following a 9-
hour incubation. TEM revealed a shortening and 
disorganisation of the microvilli on the apical cell membrane 
(compared to Fig. 3f), suggesting potential disruption resulting 
from  nanoparticle exposure (Fig. 8a and 8b). The integrity of 
the Caco-2 epithelial monolayer was not altered as tight 
junctions were still observable (Fig. 8b). Similar to the 
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hCMEC/D3 cell barrier, 50 nm SiO2 nanoparticles were mainly 
internalised in endo-lysosomal pathway-related organelles, such 
as endosomes (Fig. 8c), multivesicular bodies (Fig. 8d) and 
lysosomes (Fig. 8a, 8b, 8d and 8e). A single nanoparticle 
seemed to be trafficked within a sorting vesicle and transported 
close to the basal membrane of the monolayer (Fig. 8f), 
although no evidence of trancytosis of SiO2 nanoparticles 
across the Caco-2 cell barrier was found by TEM.  
 
Figure 8. Internalisation of 50 nm SiO2 nanoparticles (SiO2-NPs) (100 μg/ml) by Caco-2 cell monolayer post 9-hour exposure. (a) 
Microvilli appeared to lose integrity and SiO2-NPs were found co-localised within a lysosome (indicated by the arrow). (b) Tight 
junctions remaining associated with neighbouring cells and maintaining the integrity of the Caco-2 barrier, and one single SiO2-NP 
was also found in a lysosome (the arrow). More nanoparticles were found co-localised with late endosome (c), microvesicular 
body (d) and lysosomes (d-e). Another single SiO2-NP was seen in a sorting vesicle (f). Abbreviations: CCV, clathrin-coated 
vesicle; E, endosome; LE, late endosome; L, lysosome; M, mitochondria; MV, multivesicular body; N, nucleus.  
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4. Discussion 
4.1 Barrier models – cell types  
 
The human blood-brain barrier is a structure in brain capillary 
vessels, where a single layer of endothelial cells lines the wall 
of blood vessels and forms an impermeable barrier regulating 
molecule access to the central nerves system (CNS). The 
functions of the blood-brain barrier are to maintain the 
extracellular environment of the central nervous system (CNS), 
balance brain fluid homeostasis via the blood stream and 
protect the CNS from injury and disease. One well-known 
model involves human capillary microvascular endothelial cells 
(hCMEC/D3) grown on collagen-coated permeable filters.8-13, 22 
Once polarised in vitro, these cells express typical endothelial 
markers such as CD31, VE-cadherin, maintain contact-inhibited 
monolayers, and demonstrate excellent tight junction formation 
and a high capacity to exclude drugs.8, 12, 13 The hCMEC/D3 
cell monolayer has been used to investigate compound transport 
mechanisms, as well as active transport of proteins such as 
ABCB1 and ABCC1 that mediate the active efflux machinery 
for drugs,8, 36 as well as to investigate the transport of 
nanoparticles across the BBB.10, 11, 22  
 
The intestinal barrier is part of the human gastrointestinal (GI) 
tract and functions as an absorption interface between the 
external environment and the body.37 The intestinal epithelia 
are mainly responsible for absorption of nutrients in the GI 
tract. Human intestine is covered by a single layer of epithelial 
cells that form an associated network and regulate the intake of 
biomolecules and drug compounds from intestinal brush-border 
membranes to the blood.7 The Caco-2 cell barrier is well-
characterised and known for its compatibility with various 
permeable filters used to predict drug absorption and 
permeability. In culture, Caco-2 cells can slowly seal the 
transwell membrane and spontaneously differentiate into a 
monolayer with many analogous functions to the in vivo small 
intestinal villus epithelium.7, 14, 23 Some of the most 
representative subcellular structures, such as tight junctions, 
drug transport resistant proteins (e.g., P-gp, BCRP or MRP2) 
and microvilli consistently appear following polarisation of 
Caco-2 cell monolayers. Using such a confluent layer of Caco-2 
cells, a small piece of human gastrointestinal epithelia can be 
easily assembled for experimental purposes. 
 
4.2 Transwell filters – material and pore size 
 
Transwell permeable supports are commercially available in 
three membrane materials: polycarbonate (PC), polyester 
(PET), and collagen-coated polytetrafluoroethylene (PTFE), 
depending on the application and the measurement modality to 
be utilised. Selecting the correct pore size (typically 0.4, 1.0, 
3.0, 8.0 microns) for experiments using Transwell® permeable 
supports is also very important, both to ensure good cell growth 
and viability and to ensure optimal barrier morphology. 
Additionally, the membranes can be coated with a variety of 
extra-cellular matrix components, such as collagen and 
fibrinogen. Transwell manufacturers such as Corning provide 
excellent technical guidance on the selection of appropriate 
transwells for different applications. The TEM protocol 
outlined here enables detailed assessment of the morphology of 
the resultant barrier monolayers and can be used to determine 
whether further optimisation of the growth conditions 
(including the transwell filter composition or pore size) is 
required, for example if cells are observed to be growing into 
the pores, or if significant gaps remain in the surface coverage 
of the transwell filter. 
 
For studies involving nanoparticle uptake or transport, an 
additional set of considerations emerge regarding the potential 
for interaction of the nanoparticles with the pores of the 
transwell membranes. We found that nanoparticles can 
potentially adhere to the pores in various types of filters, 
remaining within the filter without moving through to the 
basolateral chamber and resulting in false negative results for 
transport studies based on determination of particles in the 
basolateral chamber.10 Therefore, it is necessary to perform 
quality control experiments whereby interactions between the 
nanoparticles and the selected transwells are performed in the 
absence of cells. TEM imaging is an excellent tool to assess 
whether these issues apply with the selected in vitro transwell 
system.  
 
4.3 Electron microscopy preparation and imaging 
considerations 
 
The protocol from 2010 for preparation of cells for assessing 
ultrastructural localisation of nanoparticles with TEM,19 gives 
an excellent summary of many of the critical aspects of TEM 
imaging considerations, which are also relevant to this protocol. 
Thus, we focus here only on those aspects of relevance 
specifically for the in vitro barrier models, both for quality 
assurance purposes and for nanoparticle transport studies across 
biological barriers. 
 
In particular, it is valuable to mention that the filter membrane 
plays an important role in TEM imaging of biological barriers, 
not only because it supports barrier formation, but also because 
it acts as a reference object for orientation of the slides during 
image analysis. The protocol given in detail above describes a 
technique that protects the monolayer-filter cross sections from 
falling apart and enables determination of the orientation of cell 
monolayer polarity. 
 
TEM was used as the primary tool to control the quality of 
biological barriers and to visualize their cellular structures, 
including those related to barrier formation such as tight 
junctions. TEM also enabled visualisation of the localisation of 
nanoparticles in cellular organelles such as endosomes, 
lysosomes and at the basolateral membrane (if transcytosis was 
occurring). More importantly, an important goal of using TEM 
imaging was to capture events of nanoparticle interaction with 
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cell monolayers and acquire conclusive evidence to reveal 
transport mechanisms for nanoparticles. 
 
Because transwell filters may physically trap nanoparticles and 
hinder their passage through the pores, resulting in quantitative 
loss of nanoparticles and deviation of experimental data despite 
their being transcytosed by endothelial or epithelial cell 
monolayers,10 it is essential to assess the interaction of 
nanoparticles with the transwells in the absence of cells also. 
 
Understanding the direction of nanoparticles travel from one 
side of the barrier to the other is vital for the determination of 
transport routes, particularly when investigating endocytosis, or 
exocytosis versus transcytosis processes in which the directions 
of movement are opposed. Although TEM users are 
presumably capable of identifying the apical or basal sides of 
polarized endothelial monolayer from experience, preserving 
the filters which exist underneath the BBB layer provides an 
additional orientation guide. Additionally, it is likely that filter 
membrane removal from cell monolayer sections may cause 
loss of critical details under the basal cell membrane and lead to 
light overexposure during object imaging, especially when 
studying nanoparticle trafficking processes, exocytosis or 
transcytosis. The protocol reported here preserves the filter 
intact with the barrier cells throughout sectioning, ensuring no 
loss of vital information, and providing an orientation guide for 
imaging and data interpretation (as well as information 
regarding particle interaction with the membrane pores).  
 
Another potential problem with transport studies across barriers 
utilising fluorescently-tagged nanoparticles is that the 
quantification of nanoparticles in the basolateral chamber is 
often performed via measurement of fluorescence from the 
nanoparticles.  However, it is becoming quite well known that 
the dyes incorporated into nanoparticles may leak from the 
nanoparticles, e.g., silica10, 38 or polystyrene39 nanoparticles, 
potentially resulting from the influence of the biological 
conditions, such as temperature, pH and cell culture medium21. 
Dye leakage may cause false signals during nanoparticle 
quantification, especially in cases where the nanoparticles 
themselves remain trapped in the barrier cells or the filters, and 
only TEM imaging can demonstrate the precise location of the 
particles visually.  
 
4.4 Confirmation of barrier functionality via TEER and FD 
transport 
 
Prior to transport studies it is standard practice to perform some 
well-established tests to confirm that the barrier functionality 
has been attained, such as the FITC-Dextran (FD) transport 
assay to test permeability and transepithelial/transendothelial 
electrical resistance (TEER) measurement. The principles of 
these two techniques are related to the restrictive effect of a 
functional barrier on paracellular transport of molecules or ions. 
FD is a paracellular marker which can passively diffuse through 
the intercellular space of biological barriers.40, 41 When a cell 
monolayer is established in a transwell system, FD is applied to 
the upper compartment, and is able to travel through the barrier 
and reach the lower compartment. Using a time-elapsed 
sampling method, transported FD is quantified on the basis of 
the fluorescence in the basolateral side, whereby a fluorescence 
versus concentration flux curve is obtained. According to the 
previously reported equation,7, 42 the permeability of FD can be 
calculated via the slope of flux curve and the initial FD dosing 
concentration. On the other hand, small ions passing through a 
cell barrier can be accessed via TEER which measures the 
impediment introduced by tight junctions formed in a confluent 
cell barrier.43 Depending on the type of barrier (endothelial or 
epithelial), TEER is either trans-endothelial or trans-epithelial 
electrical resistance. By applying an electrical current over the 
two sides of a transwell system, a voltammeter reading can be 
acquired which is the resistance provided by the barrier. 4 KDa 
FITC-Dextran (FD4) transport and TEER measurements have 
been widely used as parameters to evaluate the status of barrier 
integrity.8, 11, 13, 16, 41 In a barrier model, their results provide 
information about tight junction expression quality and allow 
comparison with other reported results obtained and with in 
vivo values (although in vitro values are consistently lower).     
 
4.5 Nanoparticle types 
 
The selection of nanoparticles used for TEM imaging analysis 
is dependent on their electron density. Many nanoparticles, 
including silica, titania, iron, gold, silver and other heavy 
metals, retain a rather high density under electron beam 
compared to biological samples (e.g., cells), which therefore 
provides a strong imaging contrast and excellent visibility for 
imaging studies. By contrast, other nanomaterials, such as 
polystyrene and liposomes, have an electron density that is 
closer to that of cells or tissues, therefore it is difficult to 
visualize and distinguish their structures in a complex 
biological environment by TEM. However, using a larger 
diameter of nanoparticles can help improve their visibility as 
well as improve image contrast in TEM imaging. It was 
reported that low-density polystyrene nanoparticles (100-160 
nm) could be observed within cells using TEM,9, 44 although 
their imaging relied on an improved contrast of cells provided 
by an optimised osmium tetroxide staining protocol. 
Visualization of small objects, for example, 1 nm gold 
nanoparticles within a cell, would require high resolution TEM 
imaging,45 since their contrast compared to background cellular 
components would be negligible. In our work, the sizes of our 
selected nanoparticles ranged from 10 to 50 nm, and both 
particle types (gold and silica) provided good contrast and 
could be appropriately visualized under TEM.  
 
Efficient nanoparticle internalisation and translocation within a 
cell is dependent on having a good quality starting dispersion 
(among other factors). Although nanoparticle agglomerates 
have a strong electron density under TEM, they limit effective 
interaction with cells and hinder access to cellular uptake 
pathways, such as endocytosis and transcytosis. Exocytotic 
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vesicles seem to have a size limit of ~100 nm from our results, 
and thus have a limited capacity to transport agglomerated 
nanoparticles.  
 
A last factor that needs to be taken into account when preparing 
nanoparticle dispersions for cellular uptake studies is the cell 
medium composition, as serum proteins used to supplement the 
medium can absorb to nanoparticles and form a protein 
corona,46-48 which is now known to mitigate targeting abilities 
of functionalised nanoparticles.49 A differential uptake 
efficiency of nanoparticles in the absence (serum-free) or 
presence of protein coronas of different composition has been 
illustrated with TEM imaging for cells.10, 38, 50 However, serum-
free uptake generally results from significant membrane 
damage and is not considered physiologically relevant, as 
particles would be coated with biomolecules immediately upon 
contact with the body (e.g. in the gut or lungs the relevant 
mucus/surfactant proteins bind to the particle surfaces). 
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